Hap Trading, LLC Purple Biotech Ltd. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$2.39 - $4.15 $34,177 - $59,345	-14,300 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.45 - $4.3 $28,175 - $49,450	-11,500 Reduced 44.57%	14,300 $7,000
Q4 2021 Feb 14, 2022	BUY	$3.75 - $4.67 $27,375 - $34,091	7,300 Added 39.46%	25,800 $10,000
Q3 2021 Nov 10, 2021	SELL	$4.4 - $5.59 $9,240 - $11,739	-2,100 Reduced 10.19%	18,500 $8,000
Q2 2021 Aug 11, 2021	SELL	$3.75 - $6.72 $18,375 - $32,928	-4,900 Reduced 19.22%	20,600 $21,000
Q1 2021 May 14, 2021	BUY	$3.93 - $6.99 $100,215 - $178,245	25,500 New	25,500 $21,000

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $67M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.